Synthetic Genomics is now Viridos.Click to see how algae moves us

Doug Miller

Chief Financial Officer

Doug Miller

Chief Financial Officer

Doug Miller joined Viridos as Chief Financial Officer (CFO) in 2017 with more than thirty years of experience across a range of industries. His expertise includes general financial management, buy- and sell-side M&A, capital markets, auditing, and accounting.

Doug began his career with PricewaterhouseCoopers, where he spent eighteen years as an auditor and advisor, including as partner-in-charge of the transaction services and capital markets practices in the Russian Federation. While in Russia, Doug worked in the oil and gas industry before returning to the United States. Prior to joining Viridos, Doug was CFO of capital business at CareFusion until it was acquired by Becton Dickinson and then Corporate Controller at Halozyme. Doug earned his BA from Wesleyan University and his MBA at Boston University.